TY - STD TI - New Drugs: Grounds for Refusing Application; Approval of Application; “Substantial Evidence” Defined, 21 USC §355d. https://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/html/USCODE-2010-title21-chap9-subchapV-partA-sec355.htm. Accessed Aug 2016. UR - https://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/html/USCODE-2010-title21-chap9-subchapV-partA-sec355.htm ID - ref1 ER - TY - STD TI - Guidance for Industry: Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078749.pdf. Accessed Aug 2016. UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078749.pdf ID - ref2 ER - TY - JOUR AU - Smithy, J. W. AU - Downing, N. S. AU - Ross, J. S. PY - 2014 DA - 2014// TI - Publication of pivotal efficacy trials for novel therapeutic agents approved between 2005 and 2011: a cross-sectional study JO - JAMA Intern Med VL - 174 UR - https://doi.org/10.1001/jamainternmed.2014.3438 DO - 10.1001/jamainternmed.2014.3438 ID - Smithy2014 ER - TY - STD TI - Miller JE, Korn D, Ross JS. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012. BMJ Open. 2015;5:e009758. doi:10.1136/bmjopen-2015-009758. ID - ref4 ER - TY - JOUR AU - Turner, E. H. AU - Matthews, A. M. AU - Linardatos, E. AU - Tell, R. A. AU - Rosenthal, R. PY - 2008 DA - 2008// TI - Selective publication of antidepressant trials and its influence on apparent efficacy JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMsa065779 DO - 10.1056/NEJMsa065779 ID - Turner2008 ER - TY - STD TI - The Food and Drug Administration Amendments Act of 2007. In: Public Law 110-85. https://www.gpo.gov/fdsys/pkg/PLAW-110publ85/pdf/PLAW-110publ85.pdf. UR - https://www.gpo.gov/fdsys/pkg/PLAW-110publ85/pdf/PLAW-110publ85.pdf ID - ref6 ER - TY - JOUR AU - Downing, N. S. AU - Aminawung, J. A. AU - Shah, N. D. AU - Krumholz, H. M. AU - Ross, J. S. PY - 2014 DA - 2014// TI - Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012 JO - JAMA VL - 311 UR - https://doi.org/10.1001/jama.2013.282034 DO - 10.1001/jama.2013.282034 ID - Downing2014 ER - TY - STD TI - US Food and Drug Administration (FDA). Drugs@FDA: FDA Approved Drug Products. FDA website. https://www.accessdata.fda.gov/scripts/cder/drugsatfda. Accessed Aug 2016. UR - https://www.accessdata.fda.gov/scripts/cder/drugsatfda ID - ref8 ER - TY - JOUR AU - Jadad, A. R. AU - Moore, R. A. AU - Carroll, D. AU - Jenkinson, C. AU - Reynolds, D. J. M. AU - Gavaghan, D. J. AU - McQuay, H. J. PY - 1996 DA - 1996// TI - Assessing the quality of reports of randomized clinical trials: is blinding necessary? JO - Control Clin Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(95)00134-4 DO - 10.1016/0197-2456(95)00134-4 ID - Jadad1996 ER - TY - STD TI - Phillips AT, Rathi VK, Ross JS. Publication of Clinical Studies Supporting FDA Premarket Approval for High-Risk Cardiovascular Devices Between 2011 and 2013A Cross-sectional Study. JAMA Intern Med. 2016;176(4):551-2. doi:10.1001/jamainternmed.2015.8590. ID - ref10 ER - TY - STD TI - Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. BMJ. 2015;350. ID - ref11 ER - TY - STD TI - Moreschi G, Friedlin V. Dronedarone Clinical and Statistical Review NDA 22-425. Silver Spring: US Food and Drug Administration (FDA); 2009. p. 59. ID - ref12 ER - TY - JOUR AU - Singh, B. N. AU - Connolly, S. J. AU - Crijns, H. J. G. M. AU - Roy, D. AU - Kowey, P. R. AU - Capucci, A. AU - Radzik, D. AU - Aliot, E. M. AU - Hohnloser, S. H. PY - 2007 DA - 2007// TI - Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa054686 DO - 10.1056/NEJMoa054686 ID - Singh2007 ER - TY - JOUR AU - Angelis, C. AU - Drazen, J. M. AU - Frizelle, F. A. P. AU - Haug, C. AU - Hoey, J. AU - Horton, R. AU - Kotzin, S. AU - Laine, C. AU - Marusic, A. AU - Overbeke, A. J. P. M. PY - 2004 DA - 2004// TI - Clinical trial registration: a statement from the International Committee of Medical Journal Editors JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMe048225 DO - 10.1056/NEJMe048225 ID - Angelis2004 ER - TY - JOUR AU - Anderson, M. L. AU - Chiswell, K. AU - Peterson, E. D. AU - Tasneem, A. AU - Topping, J. AU - Califf, R. M. PY - 2015 DA - 2015// TI - Compliance with results reporting at ClinicalTrials.gov JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMsa1409364 DO - 10.1056/NEJMsa1409364 ID - Anderson2015 ER -